{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:35:07Z","timestamp":1778819707851,"version":"3.51.4"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-024-03069-6","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T15:25:20Z","timestamp":1727882720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The involvement of K+ channels in depression and pharmacological effects of antidepressants on these channels"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-7147","authenticated-orcid":false,"given":"Xian-Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"3069_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617\u201327. https:\/\/doi.org\/10.1001\/archpsyc.62.6.617","journal-title":"Arch Gen Psychiatry"},{"key":"3069_CR2","doi-asserted-by":"publisher","unstructured":"Ruberto VL, Jha MK, Murrough JW. Pharmacological treatments for patients with treatment-resistant depression. Pharmaceuticals. 2020;13. https:\/\/doi.org\/10.3390\/ph13060116","DOI":"10.3390\/ph13060116"},{"key":"3069_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/15622970701227829","volume":"8","author":"M Bauer","year":"2007","unstructured":"Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry. 2007;8:67\u2013104. https:\/\/doi.org\/10.1080\/15622970701227829","journal-title":"World J Biol Psychiatry"},{"key":"3069_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.33","volume":"7","author":"DF Ionescu","year":"2017","unstructured":"Ionescu DF, Papakostas GI. Experimental medication treatment approaches for depression. Transl Psychiatry. 2017;7:e1068 https:\/\/doi.org\/10.1038\/tp.2017.33","journal-title":"Transl Psychiatry"},{"key":"3069_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fncel.2019.00087","volume":"13","author":"MV Foga\u00e7a","year":"2019","unstructured":"Foga\u00e7a MV, Duman RS. Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions. Front Cell Neurosci. 2019;13:87 https:\/\/doi.org\/10.3389\/fncel.2019.00087","journal-title":"Front Cell Neurosci"},{"key":"3069_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.biopsych.2016.02.009","volume":"80","author":"Z Ren","year":"2016","unstructured":"Ren Z, Pribiag H, Jefferson SJ, Shorey M, Fuchs T, Stellwagen D, et al. Bidirectional homeostatic regulation of a depression-related brain state by gamma-aminobutyric acidergic deficits and ketamine treatment. Biol Psychiatry. 2016;80:457\u201368. https:\/\/doi.org\/10.1016\/j.biopsych.2016.02.009","journal-title":"Biol Psychiatry"},{"key":"3069_CR7","doi-asserted-by":"publisher","first-page":"e932","DOI":"10.4088\/JCP.14m09049","volume":"75","author":"DF Ionescu","year":"2014","unstructured":"Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Slonena EE, Vande Voort JL, et al. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine. J Clin Psychiatry. 2014;75:e932\u20138. https:\/\/doi.org\/10.4088\/JCP.14m09049","journal-title":"J Clin Psychiatry"},{"key":"3069_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature25509","volume":"554","author":"Y Yang","year":"2018","unstructured":"Yang Y, Cui Y, Sang K, Dong Y, Ni Z, Ma S, et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature. 2018;554:317\u201322. https:\/\/doi.org\/10.1038\/nature25509","journal-title":"Nature"},{"key":"3069_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature25752","volume":"554","author":"Y Cui","year":"2018","unstructured":"Cui Y, Yang Y, Ni Z, Dong Y, Cai G, Foncelle A, et al. Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression. Nature. 2018;554:323\u20137. https:\/\/doi.org\/10.1038\/nature25752","journal-title":"Nature"},{"key":"3069_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40263-021-00885-y","volume":"36","author":"S Costi","year":"2022","unstructured":"Costi S, Han MH, Murrough JW. The potential of KCNQ potassium channel openers as novel antidepressants. CNS Drugs. 2022;36:207\u201316. https:\/\/doi.org\/10.1007\/s40263-021-00885-y","journal-title":"CNS Drugs"},{"key":"3069_CR11","first-page":"557","volume":"52","author":"CC Shieh","year":"2000","unstructured":"Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000;52:557\u201394.","journal-title":"Pharmacol Rev"},{"key":"3069_CR12","doi-asserted-by":"publisher","unstructured":"K\u00f6hling R, Wolfart J. Potassium channels in epilepsy. Cold Spring Harb Perspect Med. 2016;6. https:\/\/doi.org\/10.1101\/cshperspect.a022871","DOI":"10.1101\/cshperspect.a022871"},{"key":"3069_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.57.4.13","volume":"57","author":"FH Yu","year":"2005","unstructured":"Yu FH, Yarov-Yarovoy V, Gutman GA, Catterall WA. Overview of molecular relationships in the voltage-gated ion channel superfamily. Pharmacol Rev. 2005;57:387\u201395. https:\/\/doi.org\/10.1124\/pr.57.4.13","journal-title":"Pharmacol Rev"},{"key":"3069_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2010.08.067","volume":"486","author":"AJ Norris","year":"2010","unstructured":"Norris AJ, Foeger NC, Nerbonne JM. Neuronal voltage-gated K+ (Kv) channels function in macromolecular complexes. Neurosci Lett. 2010;486:73\u20137. https:\/\/doi.org\/10.1016\/j.neulet.2010.08.067","journal-title":"Neurosci Lett"},{"key":"3069_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.00008.2017","volume":"98","author":"P Rorsman","year":"2018","unstructured":"Rorsman P, Ashcroft FM. Pancreatic \u03b2-cell electrical activity and insulin secretion: of mice and men. Physiol Rev. 2018;98:117\u2013214. https:\/\/doi.org\/10.1152\/physrev.00008.2017","journal-title":"Physiol Rev"},{"key":"3069_CR16","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1113\/jphysiol.2010.191973","volume":"588","author":"J Johnston","year":"2010","unstructured":"Johnston J, Forsythe ID, Kopp-Scheinpflug C. Going native: voltage-gated potassium channels controlling neuronal excitability. J Physiol. 2010;588:3187\u2013200. https:\/\/doi.org\/10.1113\/jphysiol.2010.191973","journal-title":"J Physiol"},{"key":"3069_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12975-013-0297-7","volume":"5","author":"NH Shah","year":"2014","unstructured":"Shah NH, Aizenman E. Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration. Transl Stroke Res. 2014;5:38\u201358. https:\/\/doi.org\/10.1007\/s12975-013-0297-7","journal-title":"Transl Stroke Res"},{"key":"3069_CR18","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2337\/db15-1737","volume":"65","author":"R Liu","year":"2016","unstructured":"Liu R, Wang H, Xu B, Chen W, Turlova E, Dong N, et al. Cerebrovascular safety of sulfonylureas: the role of KATP channels in neuroprotection and the risk of stroke in patients with type 2 diabetes. Diabetes. 2016;65:2795\u2013809. https:\/\/doi.org\/10.2337\/db15-1737","journal-title":"Diabetes"},{"key":"3069_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tips.2008.07.013","volume":"29","author":"DA Bayliss","year":"2008","unstructured":"Bayliss DA, Barrett PQ. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact. Trends Pharmacol Sci. 2008;29:566\u201375. https:\/\/doi.org\/10.1016\/j.tips.2008.07.013","journal-title":"Trends Pharmacol Sci"},{"key":"3069_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/j.1476-5381.2009.00111.x","volume":"156","author":"DA Brown","year":"2009","unstructured":"Brown DA, Passmore GM. Neural KCNQ (Kv7) channels. Br J Pharmacol. 2009;156:1185\u201395. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00111.x","journal-title":"Br J Pharmacol"},{"key":"3069_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2013.01.028","volume":"1500","author":"I Jeong","year":"2013","unstructured":"Jeong I, Choi JS, Hahn SJ. Effects of fluoxetine on cloned Kv4.3 potassium channels. Brain Res. 2013;1500:10\u201318. https:\/\/doi.org\/10.1016\/j.brainres.2013.01.028","journal-title":"Brain Res"},{"key":"3069_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.pharmthera.2018.10.003","volume":"194","author":"A Djillani","year":"2019","unstructured":"Djillani A, Pietri M, Mazella J, Heurteaux C, Borsotto M. Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin. Pharmacol Ther. 2019;194:185\u201398. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.10.003","journal-title":"Pharmacol Ther"},{"key":"3069_CR23","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.pnpbp.2006.12.018","volume":"31","author":"MP Kaster","year":"2007","unstructured":"Kaster MP, Budni J, Binfar\u00e9 RW, Santos AR, Rodrigues AL. The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:690\u20136. https:\/\/doi.org\/10.1016\/j.pnpbp.2006.12.018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3069_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4615-7302-9_2","volume":"1","author":"DA Brown","year":"1988","unstructured":"Brown DA. M currents. Ion Channels. 1988;1:55\u201394. https:\/\/doi.org\/10.1007\/978-1-4615-7302-9_2","journal-title":"Ion Channels"},{"key":"3069_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng0198-25","volume":"18","author":"NA Singh","year":"1998","unstructured":"Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet. 1998;18:25\u201329. https:\/\/doi.org\/10.1038\/ng0198-25","journal-title":"Nat Genet"},{"key":"3069_CR26","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1002\/cne.23595","volume":"522","author":"CH King","year":"2014","unstructured":"King CH, Lancaster E, Salomon D, Peles E, Scherer SS. Kv7.2 regulates the function of peripheral sensory neurons. J Comp Neurol. 2014;522:3262\u201380. https:\/\/doi.org\/10.1002\/cne.23595","journal-title":"J Comp Neurol"},{"key":"3069_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuron.2014.12.042","volume":"85","author":"JS Trimmer","year":"2015","unstructured":"Trimmer JS. Subcellular localization of K+ channels in mammalian brain neurons: remarkable precision in the midst of extraordinary complexity. Neuron. 2015;85:238\u201356. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.042","journal-title":"Neuron"},{"key":"3069_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108399","volume":"185","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yang J, Ji W, He Q, Mao L, Shu Y. A- and D-type potassium currents regulate axonal action potential repolarization in midbrain dopamine neurons. Neuropharmacology. 2021;185:108399 https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108399","journal-title":"Neuropharmacology"},{"key":"3069_CR29","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1097\/00001756-200312190-00032","volume":"14","author":"BH Choi","year":"2003","unstructured":"Choi BH, Choi JS, Ahn HS, Kim MJ, Rhie DJ, Yoon SH, et al. Fluoxetine blocks cloned neuronal A-type K+ channels Kv1.4. Neuroreport. 2003;14:2451\u20135. https:\/\/doi.org\/10.1097\/00001756-200312190-00032","journal-title":"Neuroreport"},{"key":"3069_CR30","first-page":"1","volume":"291","author":"JS Choi","year":"1999","unstructured":"Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther. 1999;291:1\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"3069_CR31","first-page":"1108","volume":"298","author":"L Perchenet","year":"2001","unstructured":"Perchenet L, Hilfiger L, Mizrahi J, Cl\u00e9ment-Chomienne O. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5. J Pharmacol Exp Ther. 2001;298:1108\u201319.","journal-title":"J Pharmacol Exp Ther"},{"key":"3069_CR32","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/sj.bjp.0701545","volume":"122","author":"J Tytgat","year":"1997","unstructured":"Tytgat J, Maertens C, Daenens P. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br J Pharmacol. 1997;122:1417\u201324. https:\/\/doi.org\/10.1038\/sj.bjp.0701545","journal-title":"Br J Pharmacol"},{"key":"3069_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00210-012-0754-y","volume":"385","author":"I Jeong","year":"2012","unstructured":"Jeong I, Yoon SH, Hahn SJ. Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 2012;385:707\u201316. https:\/\/doi.org\/10.1007\/s00210-012-0754-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3069_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/aps.2010.14","volume":"31","author":"HM Lee","year":"2010","unstructured":"Lee HM, Hahn SJ, Choi BH. Open channel block of Kv1.5 currents by citalopram. Acta Pharmacol Sin. 2010;31:429\u201335. https:\/\/doi.org\/10.1038\/aps.2010.14","journal-title":"Acta Pharmacol Sin"},{"key":"3069_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4196\/kjpp.2016.20.2.193","volume":"20","author":"HM Lee","year":"2016","unstructured":"Lee HM, Hahn SJ, Choi BH. Blockade of Kv1.5 channels by the antidepressant drug sertraline. Korean J Physiol Pharmacol. 2016;20:193\u2013200. https:\/\/doi.org\/10.4196\/kjpp.2016.20.2.193","journal-title":"Korean J Physiol Pharmacol"},{"key":"3069_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4196\/kjpp.2016.20.1.75","volume":"20","author":"HM Lee","year":"2016","unstructured":"Lee HM, Hahn SJ, Choi BH. Blockade of Kv1.5 by paroxetine, an antidepressant drug. Korean J Physiol Pharmacol. 2016;20:75\u201382. https:\/\/doi.org\/10.4196\/kjpp.2016.20.1.75","journal-title":"Korean J Physiol Pharmacol"},{"key":"3069_CR37","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1248\/bpb.33.977","volume":"33","author":"HM Lee","year":"2010","unstructured":"Lee HM, Hahn SJ, Choi BH. Inhibitory action of fluvoxamine on Kv1.5 currents. Biol Pharm Bull. 2010;33:977\u201382. https:\/\/doi.org\/10.1248\/bpb.33.977","journal-title":"Biol Pharm Bull"},{"key":"3069_CR38","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/cvr\/cvq398","volume":"89","author":"U Ravens","year":"2011","unstructured":"Ravens U, Wettwer E. Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. Cardiovasc Res. 2011;89:776\u201385. https:\/\/doi.org\/10.1093\/cvr\/cvq398","journal-title":"Cardiovasc Res"},{"key":"3069_CR39","doi-asserted-by":"publisher","first-page":"fcab285","DOI":"10.1093\/braincomms\/fcab285","volume":"3","author":"K Hashimoto","year":"2021","unstructured":"Hashimoto K, Yamawaki Y, Yamaoka K, Yoshida T, Okada K, Tan W, et al. Spike firing attenuation of serotonin neurons in learned helplessness rats is reversed by ketamine. Brain Commun. 2021;3:fcab285. https:\/\/doi.org\/10.1093\/braincomms\/fcab285","journal-title":"Brain Commun"},{"key":"3069_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0073-6","volume":"50","author":"H Lin","year":"2018","unstructured":"Lin H, Kim JG, Park SW, Noh HJ, Kim JM, Yoon CY, et al. Enhancement of 5-HT(2A) receptor function and blockade of Kv1.5 by MK801 and ketamine: implications for PCP derivative-induced disease models. Exp Mol Med. 2018;50:1\u20138. https:\/\/doi.org\/10.1038\/s12276-018-0073-6","journal-title":"Exp Mol Med"},{"key":"3069_CR41","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00424-007-0240-4","volume":"454","author":"SH Kim","year":"2007","unstructured":"Kim SH, Bae YM, Sung DJ, Park SW, Woo NS, Kim B, et al. Ketamine blocks voltage-gated K(+) channels and causes membrane depolarization in rat mesenteric artery myocytes. Pflugers Arch. 2007;454:891\u2013902. https:\/\/doi.org\/10.1007\/s00424-007-0240-4","journal-title":"Pflugers Arch"},{"key":"3069_CR42","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1152\/physrev.00002.2008","volume":"88","author":"H Vacher","year":"2008","unstructured":"Vacher H, Mohapatra DP, Trimmer JS. Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiol Rev. 2008;88:1407\u201347. https:\/\/doi.org\/10.1152\/physrev.00002.2008","journal-title":"Physiol Rev"},{"key":"3069_CR43","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1523\/JNEUROSCI.19-05-01728.1999","volume":"19","author":"H Murakoshi","year":"1999","unstructured":"Murakoshi H, Trimmer JS. Identification of the Kv2.1 K+ channel as a major component of the delayed rectifier K+ current in rat hippocampal neurons. J Neurosci. 1999;19:1728\u201335.","journal-title":"J Neurosci"},{"key":"3069_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1113\/jphysiol.2007.128454","volume":"581","author":"D Guan","year":"2007","unstructured":"Guan D, Tkatch T, Surmeier DJ, Armstrong WE, Foehring RC. Kv2 subunits underlie slowly inactivating potassium current in rat neocortical pyramidal neurons. J Physiol. 2007;581:941\u201360. https:\/\/doi.org\/10.1113\/jphysiol.2007.128454","journal-title":"J Physiol"},{"key":"3069_CR45","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/gbb.12120","volume":"13","author":"DJ Speca","year":"2014","unstructured":"Speca DJ, Ogata G, Mandikian D, Bishop HI, Wiler SW, Eum K, et al. Deletion of the Kv2.1 delayed rectifier potassium channel leads to neuronal and behavioral hyperexcitability. Genes Brain Behav. 2014;13:394\u2013408. https:\/\/doi.org\/10.1111\/gbb.12120","journal-title":"Genes Brain Behav"},{"key":"3069_CR46","doi-asserted-by":"publisher","first-page":"16404","DOI":"10.1523\/jneurosci.5291-14.2015","volume":"35","author":"T Kimm","year":"2015","unstructured":"Kimm T, Khaliq ZM, Bean BP. Differential regulation of action potential shape and burst-frequency firing by BK and Kv2 channels in substantia nigra dopaminergic neurons. J Neurosci. 2015;35:16404\u201317. https:\/\/doi.org\/10.1523\/jneurosci.5291-14.2015","journal-title":"J Neurosci"},{"key":"3069_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.apsb.2014.12.004","volume":"5","author":"C Chen","year":"2015","unstructured":"Chen C, Wang L, Rong X, Wang W, Wang X. Effects of fluoxetine on protein expression of potassium ion channels in the brain of chronic mild stress rats. Acta Pharm Sin B. 2015;5:55\u201361. https:\/\/doi.org\/10.1016\/j.apsb.2014.12.004","journal-title":"Acta Pharm Sin B"},{"key":"3069_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173097","volume":"878","author":"W Wang","year":"2020","unstructured":"Wang W, Yin H, Feng N, Wang L, Wang X. Inhibitory effects of antidepressant fluoxetine on cloned Kv2.1 potassium channel expressed in HEK293 cells. Eur J Pharmacol. 2020;878:173097. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173097","journal-title":"Eur J Pharmacol"},{"key":"3069_CR49","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1111\/dom.14791","volume":"24","author":"B Liu","year":"2022","unstructured":"Liu B, Ruz-Maldonado I, Toczyska K, Olaniru OE, Zariwala MG, Hopkins D, et al. The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta-cell mass. Diabetes Obes Metab. 2022;24:2038\u201350. https:\/\/doi.org\/10.1111\/dom.14791","journal-title":"Diabetes Obes Metab"},{"key":"3069_CR50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cmet.2007.07.010","volume":"6","author":"DA Jacobson","year":"2007","unstructured":"Jacobson DA, Kuznetsov A, Lopez JP, Kash S, Amm\u00e4l\u00e4 CE, Philipson LH. Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion. Cell Metab. 2007;6:229\u201335. https:\/\/doi.org\/10.1016\/j.cmet.2007.07.010","journal-title":"Cell Metab"},{"key":"3069_CR51","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.2337\/db16-1170","volume":"66","author":"J Fu","year":"2017","unstructured":"Fu J, Dai X, Plummer G, Suzuki K, Bautista A, Githaka JM, et al. Kv2.1 clustering contributes to insulin exocytosis and rescues human \u03b2-cell dysfunction. Diabetes. 2017;66:1890\u20131900. https:\/\/doi.org\/10.2337\/db16-1170","journal-title":"Diabetes"},{"key":"3069_CR52","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1124\/jpet.109.159160","volume":"332","author":"YL He","year":"2010","unstructured":"He YL, Zhan XQ, Yang G, Sun J, Mei YA. Amoxapine inhibits the delayed rectifier outward K+ current in mouse cortical neurons via cAMP\/protein kinase A pathways. J Pharmacol Exp Ther. 2010;332:437\u201345. https:\/\/doi.org\/10.1124\/jpet.109.159160","journal-title":"J Pharmacol Exp Ther"},{"key":"3069_CR53","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/jnr.22744","volume":"90","author":"XQ Zhan","year":"2012","unstructured":"Zhan XQ, He YL, Yao JJ, Zhuang JL, Mei YA. The antidepressant citalopram inhibits delayed rectifier outward K+ current in mouse cortical neurons. J Neurosci Res. 2012;90:324\u201336. https:\/\/doi.org\/10.1002\/jnr.22744","journal-title":"J Neurosci Res"},{"key":"3069_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep35080","volume":"6","author":"JI Stas","year":"2016","unstructured":"Stas JI, Bocksteins E, Jensen CS, Schmitt N, Snyders DJ. The anticonvulsant retigabine suppresses neuronal K(V)2-mediated currents. Sci Rep. 2016;6:35080. https:\/\/doi.org\/10.1038\/srep35080","journal-title":"Sci Rep"},{"key":"3069_CR55","doi-asserted-by":"publisher","first-page":"8829","DOI":"10.1523\/jneurosci.5176-14.2015","volume":"35","author":"BI Kalappa","year":"2015","unstructured":"Kalappa BI, Soh H, Duignan KM, Furuya T, Edwards S, Tzingounis AV, et al. Potent KCNQ2\/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus. J Neurosci. 2015;35:8829\u201342. https:\/\/doi.org\/10.1523\/jneurosci.5176-14.2015","journal-title":"J Neurosci"},{"key":"3069_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11671","volume":"7","author":"AK Friedman","year":"2016","unstructured":"Friedman AK, Juarez B, Ku SM, Zhang H, Calizo RC, Walsh JJ, et al. KCNQ channel openers reverse depressive symptoms via an active resilience mechanism. Nat Commun. 2016;7:11671. https:\/\/doi.org\/10.1038\/ncomms11671","journal-title":"Nat Commun"},{"key":"3069_CR57","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/s0166-2236(00)01892-0","volume":"24","author":"B Rudy","year":"2001","unstructured":"Rudy B, McBain CJ. Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing. Trends Neurosci. 2001;24:517\u201326. https:\/\/doi.org\/10.1016\/s0166-2236(00)01892-0","journal-title":"Trends Neurosci"},{"key":"3069_CR58","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1749-6632.1999.tb11295.x","volume":"868","author":"B Rudy","year":"1999","unstructured":"Rudy B, Chow A, Lau D, Amarillo Y, Ozaita A, Saganich M, et al. Contributions of Kv3 channels to neuronal excitability. Ann N Y Acad Sci. 1999;868:304\u201343. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb11295.x","journal-title":"Ann N Y Acad Sci"},{"key":"3069_CR59","doi-asserted-by":"publisher","first-page":"20971","DOI":"10.1016\/S0021-9258(19)36784-5","volume":"267","author":"S Grissmer","year":"1992","unstructured":"Grissmer S, Ghanshani S, Dethlefs B, McPherson JD, Wasmuth JJ, Gutman GA, et al. The Shaw-related potassium channel gene, Kv3.1, on human chromosome 11, encodes the type l K+ channel in T cells. J Biol Chem. 1992;267:20971\u20139.","journal-title":"J Biol Chem"},{"key":"3069_CR60","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1523\/jneurosci.0722-05.2005","volume":"25","author":"EM Goldberg","year":"2005","unstructured":"Goldberg EM, Watanabe S, Chang SY, Joho RH, Huang ZJ, Leonard CS, et al. Specific functions of synaptically localized potassium channels in synaptic transmission at the neocortical GABAergic fast-spiking cell synapse. J Neurosci. 2005;25:5230\u20135. https:\/\/doi.org\/10.1523\/jneurosci.0722-05.2005","journal-title":"J Neurosci"},{"key":"3069_CR61","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/npp.2017.155","volume":"43","author":"PK Parekh","year":"2018","unstructured":"Parekh PK, Sidor MM, Gillman A, Becker-Krail D, Bettelini L, Arban R, et al. Antimanic efficacy of a novel Kv3 potassium channel modulator. Neuropsychopharmacology. 2018;43:435\u201344. https:\/\/doi.org\/10.1038\/npp.2017.155","journal-title":"Neuropsychopharmacology"},{"key":"3069_CR62","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1046\/j.1601-183x.2003.00054.x","volume":"3","author":"F Espinosa","year":"2004","unstructured":"Espinosa F, Marks G, Heintz N, Joho RH. Increased motor drive and sleep loss in mice lacking Kv3-type potassium channels. Genes Brain Behav. 2004;3:90\u2013100. https:\/\/doi.org\/10.1046\/j.1601-183x.2003.00054.x","journal-title":"Genes Brain Behav"},{"key":"3069_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.biopsych.2020.02.1179","volume":"88","author":"L Medrihan","year":"2020","unstructured":"Medrihan L, Umschweif G, Sinha A, Reed S, Lee J, Gindinova K, et al. Reduced Kv3.1 activity in dentate gyrus parvalbumin cells induces vulnerability to depression. Biol Psychiatry. 2020;88:405\u201314. https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.1179","journal-title":"Biol Psychiatry"},{"key":"3069_CR64","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1254\/jphs.fp0070759","volume":"106","author":"MJ Sung","year":"2008","unstructured":"Sung MJ, Ahn HS, Hahn SJ, Choi BH. Open channel block of Kv3.1 currents by fluoxetine. J Pharmacol Sci. 2008;106:38\u201345. https:\/\/doi.org\/10.1254\/jphs.fp0070759","journal-title":"J Pharmacol Sci"},{"key":"3069_CR65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4196\/kjpp.2018.22.1.71","volume":"22","author":"HM Lee","year":"2018","unstructured":"Lee HM, Chai OH, Hahn SJ, Choi BH. Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel. Korean J Physiol Pharmacol. 2018;22:71\u201380. https:\/\/doi.org\/10.4196\/kjpp.2018.22.1.71","journal-title":"Korean J Physiol Pharmacol"},{"key":"3069_CR66","doi-asserted-by":"publisher","unstructured":"Tabka H, Cheikh A, Maatoug S, Ayeb ME, Bendahhou S, Benkhalifa R. First evidence of Kv3.1b potassium channel subtype expression during neuronal serotonergic 1C11 cell line development. Int J Mol Sci 2020;21. https:\/\/doi.org\/10.3390\/ijms21197175","DOI":"10.3390\/ijms21197175"},{"key":"3069_CR67","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41380-019-0379-3","volume":"25","author":"Y Sagi","year":"2020","unstructured":"Sagi Y, Medrihan L, George K, Barney M, McCabe KA, Greengard P. Emergence of 5-HT5A signaling in parvalbumin neurons mediates delayed antidepressant action. Mol Psychiatry. 2020;25:1191\u2013201. https:\/\/doi.org\/10.1038\/s41380-019-0379-3","journal-title":"Mol Psychiatry"},{"key":"3069_CR68","doi-asserted-by":"publisher","unstructured":"Hsiao HT, Wang JC, Wu SN. Inhibitory effectiveness in delayed-rectifier potassium current caused by vortioxetine, known to be a novel antidepressant. Biomedicines. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10061318","DOI":"10.3390\/biomedicines10061318"},{"key":"3069_CR69","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1152\/jn.1998.79.2.1081","volume":"79","author":"P Ser\u00f4dio","year":"1998","unstructured":"Ser\u00f4dio P, Rudy B. Differential expression of Kv4 K+ channel subunits mediating subthreshold transient K+ (A-type) currents in rat brain. J Neurophysiol. 1998;79:1081\u201391. https:\/\/doi.org\/10.1152\/jn.1998.79.2.1081","journal-title":"J Neurophysiol"},{"key":"3069_CR70","first-page":"262","volume":"282","author":"LE Schechter","year":"1997","unstructured":"Schechter LE. The potassium channel blockers 4-aminopyridine and tetraethylammonium increase the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices. J Pharmacol Exp Ther. 1997;282:262\u201370.","journal-title":"J Pharmacol Exp Ther"},{"key":"3069_CR71","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.neuropharm.2011.12.006","volume":"62","author":"I Jeong","year":"2012","unstructured":"Jeong I, Kim SW, Yoon SH, Hahn SJ. Block of cloned Kv4.3 potassium channels by dapoxetine. Neuropharmacology. 2012;62:2261\u20136. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.006","journal-title":"Neuropharmacology"},{"key":"3069_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2012.05.028","volume":"1466","author":"JS Choi","year":"2012","unstructured":"Choi JS, Hahn SJ. Duloxetine blocks cloned Kv4.3 potassium channels. Brain Res. 2012;1466:15\u201323. https:\/\/doi.org\/10.1016\/j.brainres.2012.05.028","journal-title":"Brain Res"},{"key":"3069_CR73","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/00005344-199810000-00004","volume":"32","author":"O Casis","year":"1998","unstructured":"Casis O, S\u00e1nchez-Chapula JA. Mechanism of block of cardiac transient outward K+ current (I(to)) by antidepressant drugs. J Cardiovasc Pharmacol. 1998;32:527\u201334. https:\/\/doi.org\/10.1097\/00005344-199810000-00004","journal-title":"J Cardiovasc Pharmacol"},{"key":"3069_CR74","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1113\/jphysiol.2008.150656","volume":"586","author":"S Maljevic","year":"2008","unstructured":"Maljevic S, Wuttke TV, Lerche H. Nervous system KV7 disorders: breakdown of a subthreshold brake. J Physiol. 2008;586:1791\u2013801. https:\/\/doi.org\/10.1113\/jphysiol.2008.150656","journal-title":"J Physiol"},{"key":"3069_CR75","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","volume":"282","author":"HS Wang","year":"1998","unstructured":"Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science. 1998;282:1890\u20133. https:\/\/doi.org\/10.1126\/science.282.5395.1890","journal-title":"Science"},{"key":"3069_CR76","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/npp.2017.68","volume":"42","author":"S Kang","year":"2017","unstructured":"Kang S, Li J, Zuo W, Fu R, Gregor D, Krnjevic K, et al. Ethanol withdrawal drives anxiety-related behaviors by reducing M-type potassium channel activity in the lateral habenula. Neuropsychopharmacology. 2017;42:1813\u201324. https:\/\/doi.org\/10.1038\/npp.2017.68","journal-title":"Neuropsychopharmacology"},{"key":"3069_CR77","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1176\/appi.ajp.2020.20050653","volume":"178","author":"S Costi","year":"2021","unstructured":"Costi S, Morris LS, Kirkwood KA, Hoch M, Corniquel M, Vo-Le B, et al. Impact of the KCNQ2\/3 channel opener ezogabine on reward circuit activity and clinical symptoms in depression: results from a randomized controlled trial. Am J Psychiatry. 2021;178:437\u201346. https:\/\/doi.org\/10.1176\/appi.ajp.2020.20050653","journal-title":"Am J Psychiatry"},{"key":"3069_CR78","doi-asserted-by":"publisher","first-page":"173440","DOI":"10.1016\/j.ejphar.2020.173440","volume":"887","author":"M Grupe","year":"2020","unstructured":"Grupe M, Bentzen BH, Benned-Jensen T, Nielsen V, Frederiksen K, Jensen HS, et al. In vitro and in vivo characterization of Lu AA41178: A novel, brain penetrant, pan-selective Kv7 potassium channel opener with efficacy in preclinical models of epileptic seizures and psychiatric disorders. Eur J Pharmacol. 2020;887:173440. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173440","journal-title":"Eur J Pharmacol"},{"key":"3069_CR79","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1111\/bph.14026","volume":"174","author":"L Li","year":"2017","unstructured":"Li L, Sun H, Ding J, Niu C, Su M, Zhang L, et al. Selective targeting of M-type potassium K(v) 7.4 channels demonstrates their key role in the regulation of dopaminergic neuronal excitability and depression-like behaviour. Br J Pharmacol. 2017;174:4277\u201394. https:\/\/doi.org\/10.1111\/bph.14026","journal-title":"Br J Pharmacol"},{"key":"3069_CR80","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/j.neuron.2022.05.001","volume":"110","author":"JP Lopez","year":"2022","unstructured":"Lopez JP, L\u00fccken MD, Brivio E, Karamihalev S, Kos A, De Donno C, et al. Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2. Neuron. 2022;110:2283\u201398.e2289. https:\/\/doi.org\/10.1016\/j.neuron.2022.05.001","journal-title":"Neuron"},{"key":"3069_CR81","first-page":"723","volume":"50","author":"M Yamada","year":"1998","unstructured":"Yamada M, Inanobe A, Kurachi Y. G protein regulation of potassium ion channels. Pharmacol Rev. 1998;50:723\u201360.","journal-title":"Pharmacol Rev"},{"key":"3069_CR82","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev.physiol.59.1.171","volume":"59","author":"CG Nichols","year":"1997","unstructured":"Nichols CG, Lopatin AN. Inward rectifier potassium channels. Annu Rev Physiol. 1997;59:171\u201391. https:\/\/doi.org\/10.1146\/annurev.physiol.59.1.171","journal-title":"Annu Rev Physiol"},{"key":"3069_CR83","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1046\/j.1432-1327.2000.01669.x","volume":"267","author":"D Oliver","year":"2000","unstructured":"Oliver D, Baukrowitz T, Fakler B. Polyamines as gating molecules of inward-rectifier K+ channels. Eur J Biochem. 2000;267:5824\u20139. https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01669.x","journal-title":"Eur J Biochem"},{"key":"3069_CR84","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1152\/physrev.00021.2009","volume":"90","author":"H Hibino","year":"2010","unstructured":"Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev. 2010;90:291\u2013366. https:\/\/doi.org\/10.1152\/physrev.00021.2009","journal-title":"Physiol Rev"},{"key":"3069_CR85","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1152\/jn.00996.2005","volume":"95","author":"C Neusch","year":"2006","unstructured":"Neusch C, Papadopoulos N, M\u00fcller M, Maletzki I, Winter SM, Hirrlinger J, et al. Lack of the Kir4.1 channel subunit abolishes K+ buffering properties of astrocytes in the ventral respiratory group: impact on extracellular K+ regulation. J Neurophysiol. 2006;95:1843\u201352. https:\/\/doi.org\/10.1152\/jn.00996.2005","journal-title":"J Neurophysiol"},{"key":"3069_CR86","doi-asserted-by":"publisher","unstructured":"Della Vecchia S, Marchese M, Santorelli FM, Sicca F Kir4.1 Dysfunction in the pathophysiology of depression: a systematic review. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10102628","DOI":"10.3390\/cells10102628"},{"key":"3069_CR87","doi-asserted-by":"publisher","unstructured":"Ohno Y, Kunisawa N, Shimizu S. Emerging roles of astrocyte Kir4.1 channels in the pathogenesis and treatment of brain diseases. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms221910236","DOI":"10.3390\/ijms221910236"},{"key":"3069_CR88","doi-asserted-by":"publisher","unstructured":"Zhou X, Zhao C, Xu H, Xu Y, Zhan L, Wang P, et al. Pharmacological inhibition of Kir4.1 evokes rapid-onset antidepressant responses. Nat Chem Biol. 2024. https:\/\/doi.org\/10.1038\/s41589-024-01555-y","DOI":"10.1038\/s41589-024-01555-y"},{"key":"3069_CR89","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.conb.2017.10.024","volume":"48","author":"Y Yang","year":"2018","unstructured":"Yang Y, Wang H, Hu J, Hu H. Lateral habenula in the pathophysiology of depression. Curr Opin Neurobiol. 2018;48:90\u20136. https:\/\/doi.org\/10.1016\/j.conb.2017.10.024","journal-title":"Curr Opin Neurobiol"},{"key":"3069_CR90","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnsyn.2018.00046","volume":"10","author":"CA Browne","year":"2018","unstructured":"Browne CA, Hammack R, Lucki I. Dysregulation of the lateral habenula in major depressive disorder. Front Synaptic Neurosci. 2018;10:46 https:\/\/doi.org\/10.3389\/fnsyn.2018.00046","journal-title":"Front Synaptic Neurosci"},{"key":"3069_CR91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11064-019-02744-1","volume":"45","author":"M Stenovec","year":"2020","unstructured":"Stenovec M, Bo\u017ei\u0107 M, Pirnat S, Zorec R. Astroglial mechanisms of ketamine action include reduced mobility of Kir4.1-carrying vesicles. Neurochem Res. 2020;45:109\u201321. https:\/\/doi.org\/10.1007\/s11064-019-02744-1","journal-title":"Neurochem Res"},{"key":"3069_CR92","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1523\/jneurosci.16-22-07137.1996","volume":"16","author":"YJ Liao","year":"1996","unstructured":"Liao YJ, Jan YN, Jan LY. Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain. J Neurosci. 1996;16:7137\u201350. https:\/\/doi.org\/10.1523\/jneurosci.16-22-07137.1996","journal-title":"J Neurosci"},{"key":"3069_CR93","doi-asserted-by":"publisher","unstructured":"Stenovec M. Ketamine alters functional plasticity of astroglia: an implication for antidepressant effect. Life. 2021;11. https:\/\/doi.org\/10.3390\/life11060573","DOI":"10.3390\/life11060573"},{"key":"3069_CR94","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2007.08.018","volume":"1178","author":"Y Ohno","year":"2007","unstructured":"Ohno Y, Hibino H, Lossin C, Inanobe A, Kurachi Y. Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors. Brain Res. 2007;1178:44\u201351. https:\/\/doi.org\/10.1016\/j.brainres.2007.08.018","journal-title":"Brain Res"},{"key":"3069_CR95","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1124\/mol.118.112359","volume":"94","author":"SV Kharade","year":"2018","unstructured":"Kharade SV, Kurata H, Bender AM, Blobaum AL, Figueroa EE, Duran A, et al. Discovery, characterization, and effects on renal fluid and electrolyte excretion of the Kir4.1 potassium channel pore blocker, VU0134992. Mol Pharmacol. 2018;94:926\u201337. https:\/\/doi.org\/10.1124\/mol.118.112359","journal-title":"Mol Pharmacol"},{"key":"3069_CR96","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrn2834","volume":"11","author":"C L\u00fcscher","year":"2010","unstructured":"L\u00fcscher C, Slesinger PA. Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci. 2010;11:301\u201315. https:\/\/doi.org\/10.1038\/nrn2834","journal-title":"Nat Rev Neurosci"},{"key":"3069_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107808","volume":"223","author":"D Jeremic","year":"2021","unstructured":"Jeremic D, Sanchez-Rodriguez I, Jimenez-Diaz L, Navarro-Lopez JD. Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system. Pharmacol Ther. 2021;223:107808 https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107808","journal-title":"Pharmacol Ther"},{"key":"3069_CR98","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/sj.bjp.0705172","volume":"138","author":"T Kobayashi","year":"2003","unstructured":"Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac). Br J Pharmacol. 2003;138:1119\u201328. https:\/\/doi.org\/10.1038\/sj.bjp.0705172","journal-title":"Br J Pharmacol"},{"key":"3069_CR99","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1254\/jphs.fp0060708","volume":"102","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine. J Pharmacol Sci. 2006;102:278\u201387. https:\/\/doi.org\/10.1254\/jphs.fp0060708","journal-title":"J Pharmacol Sci"},{"key":"3069_CR100","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/sj.npp.1300484","volume":"29","author":"T Kobayashi","year":"2004","unstructured":"Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs. Neuropsychopharmacology. 2004;29:1841\u201351. https:\/\/doi.org\/10.1038\/sj.npp.1300484","journal-title":"Neuropsychopharmacology"},{"key":"3069_CR101","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/npp.2010.27","volume":"35","author":"T Kobayashi","year":"2010","unstructured":"Kobayashi T, Washiyama K, Ikeda K. Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine. Neuropsychopharmacology. 2010;35:1560\u20139. https:\/\/doi.org\/10.1038\/npp.2010.27","journal-title":"Neuropsychopharmacology"},{"key":"3069_CR102","doi-asserted-by":"publisher","first-page":"e28208","DOI":"10.1371\/journal.pone.0028208","volume":"6","author":"T Kobayashi","year":"2011","unstructured":"Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants. PLoS ONE. 2011;6:e28208. https:\/\/doi.org\/10.1371\/journal.pone.0028208","journal-title":"PLoS ONE"},{"key":"3069_CR103","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1176\/jnp.5.3.322","volume":"5","author":"CN Karson","year":"1993","unstructured":"Karson CN, Newton JE, Livingston R, Jolly JB, Cooper TB, Sprigg J, et al. Human brain fluoxetine concentrations. J Neuropsychiatry Clin Neurosci. 1993;5:322\u20139. https:\/\/doi.org\/10.1176\/jnp.5.3.322","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"3069_CR104","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/s0893-133x(00)00116-0","volume":"23","author":"NR Bolo","year":"2000","unstructured":"Bolo NR, Hod\u00e9 Y, N\u00e9d\u00e9lec JF, Lain\u00e9 E, Wagner G, Macher JP. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology. 2000;23:428\u201338. https:\/\/doi.org\/10.1016\/s0893-133x(00)00116-0","journal-title":"Neuropsychopharmacology"},{"key":"3069_CR105","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018;23:801\u201311. https:\/\/doi.org\/10.1038\/mp.2017.255","journal-title":"Mol Psychiatry"},{"key":"3069_CR106","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/mp.2014.165","volume":"20","author":"ER Workman","year":"2015","unstructured":"Workman ER, Haddick PC, Bush K, Dilly GA, Niere F, Zemelman BV, et al. Rapid antidepressants stimulate the decoupling of GABA(B) receptors from GIRK\/Kir3 channels through increased protein stability of 14-3-3\u03b7. Mol Psychiatry. 2015;20:298\u2013310. https:\/\/doi.org\/10.1038\/mp.2014.165","journal-title":"Mol Psychiatry"},{"key":"3069_CR107","first-page":"283","volume":"94","author":"JL Neely","year":"1998","unstructured":"Neely JL. Tonic clonic seizures and tachycardia induced by fluoxetine (Prozac) overdose. W V Med J. 1998;94:283\u20135.","journal-title":"W V Med J"},{"key":"3069_CR108","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1111\/j.1528-1157.1999.tb00885.x","volume":"40","author":"F Pisani","year":"1999","unstructured":"Pisani F, Spina E, Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia. 1999;40:S48\u201356. https:\/\/doi.org\/10.1111\/j.1528-1157.1999.tb00885.x","journal-title":"Epilepsia"},{"key":"3069_CR109","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1073\/pnas.94.3.923","volume":"94","author":"S Signorini","year":"1997","unstructured":"Signorini S, Liao YJ, Duncan SA, Jan LY, Stoffel M. Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2. Proc Natl Acad Sci USA. 1997;94:923\u20137. https:\/\/doi.org\/10.1073\/pnas.94.3.923","journal-title":"Proc Natl Acad Sci USA"},{"key":"3069_CR110","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/cne.20469","volume":"484","author":"A Thomzig","year":"2005","unstructured":"Thomzig A, Laube G, Pr\u00fcss H, Veh RW. Pore-forming subunits of K-ATP channels, Kir6.1 and Kir6.2, display prominent differences in regional and cellular distribution in the rat brain. J Comp Neurol. 2005;484:313\u201330. https:\/\/doi.org\/10.1002\/cne.20469","journal-title":"J Comp Neurol"},{"key":"3069_CR111","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00210-019-01636-z","volume":"392","author":"S Shakiba","year":"2019","unstructured":"Shakiba S, Rezaee M, Afshari K, Kazemi K, Sharifi KA, Haddadi NS, et al. Evaluation of the pharmacological involvement of ATP-sensitive potassium (K(ATP)) channels in the antidepressant-like effects of topiramate on mice. Naunyn Schmiedebergs Arch Pharmacol. 2019;392:833\u201342. https:\/\/doi.org\/10.1007\/s00210-019-01636-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3069_CR112","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/fbp.0000000000000600","volume":"32","author":"M Ajaman","year":"2021","unstructured":"Ajaman M, Naserzadeh R, Ghorbanzadeh B. Pharmacological evaluation of NO\/cGMP\/KATP channels pathway in the antidepressant-like effect of carbamazepine in mice. Behav Pharmacol. 2021;32:32\u201342. https:\/\/doi.org\/10.1097\/fbp.0000000000000600","journal-title":"Behav Pharmacol"},{"key":"3069_CR113","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pbb.2019.03.002","volume":"180","author":"R Naserzadeh","year":"2019","unstructured":"Naserzadeh R, Abad N, Ghorbanzadeh B, Dolatshahi M, Mansouri MT. Simvastatin exerts antidepressant-like activity in mouse forced swimming test: role of NO-cGMP-K(ATP) channels pathway and PPAR-gamma receptors. Pharmacol Biochem Behav. 2019;180:92\u2013100. https:\/\/doi.org\/10.1016\/j.pbb.2019.03.002","journal-title":"Pharmacol Biochem Behav"},{"key":"3069_CR114","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1139\/cjpp-2016-0292","volume":"95","author":"S Ostadhadi","year":"2017","unstructured":"Ostadhadi S, Akbarian R, Norouzi-Javidan A, Nikoui V, Zolfaghari S, Chamanara M, et al. Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effects of gabapentin in mouse forced swimming test. Can J Physiol Pharmacol. 2017;95:795\u2013802. https:\/\/doi.org\/10.1139\/cjpp-2016-0292","journal-title":"Can J Physiol Pharmacol"},{"key":"3069_CR115","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.pharep.2016.07.006","volume":"68","author":"SK Nazari","year":"2016","unstructured":"Nazari SK, Nikoui V, Ostadhadi S, Chegini ZH, Oryan S, Bakhtiarian A. Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effect of baclofen in mouse forced swimming test. Pharmacol Rep. 2016;68:1214\u201320. https:\/\/doi.org\/10.1016\/j.pharep.2016.07.006","journal-title":"Pharmacol Rep"},{"key":"3069_CR116","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/toxsci\/kfx090","volume":"158","author":"E Elmorsy","year":"2017","unstructured":"Elmorsy E, Al-Ghafari A, Helaly ANM, Hisab AS, Oehrle B, Smith PA. Editor\u2019s highlight: therapeutic concentrations of antidepressants inhibit pancreatic beta-cell function via mitochondrial complex inhibition. Toxicol Sci. 2017;158:286\u2013301. https:\/\/doi.org\/10.1093\/toxsci\/kfx090","journal-title":"Toxicol Sci"},{"key":"3069_CR117","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1124\/mol.59.2.225","volume":"59","author":"Y Liu","year":"2001","unstructured":"Liu Y, Ren G, O\u2019Rourke B, Marb\u00e1n E, Seharaseyon J. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. Mol Pharmacol. 2001;59:225\u201330.","journal-title":"Mol Pharmacol"},{"key":"3069_CR118","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/bs.irn.2016.04.001","volume":"128","author":"C Contet","year":"2016","unstructured":"Contet C, Goulding SP, Kuljis DA, Barth AL. BK channels in the central nervous system. Int Rev Neurobiol. 2016;128:281\u2013342. https:\/\/doi.org\/10.1016\/bs.irn.2016.04.001","journal-title":"Int Rev Neurobiol"},{"key":"3069_CR119","doi-asserted-by":"publisher","first-page":"750615","DOI":"10.3389\/fphys.2021.750615","volume":"12","author":"M Sancho","year":"2021","unstructured":"Sancho M, Kyle BD. The large-conductance, calcium-activated potassium channel: a big key regulator of cell physiology. Front Physiol. 2021;12:750615. https:\/\/doi.org\/10.3389\/fphys.2021.750615","journal-title":"Front Physiol"},{"key":"3069_CR120","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.physbeh.2014.10.005","volume":"138","author":"P Sun","year":"2015","unstructured":"Sun P, Zhang Q, Zhang Y, Wang F, Wang L, Yamamoto R, et al. Fear conditioning suppresses large-conductance calcium-activated potassium channels in lateral amygdala neurons. Physiol Behav. 2015;138:279\u201384. https:\/\/doi.org\/10.1016\/j.physbeh.2014.10.005","journal-title":"Physiol Behav"},{"key":"3069_CR121","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1113\/jphysiol.2006.121582","volume":"578","author":"A Mathie","year":"2007","unstructured":"Mathie A. Neuronal two-pore-domain potassium channels and their regulation by G protein-coupled receptors. J Physiol. 2007;578:377\u201385. https:\/\/doi.org\/10.1113\/jphysiol.2006.121582","journal-title":"J Physiol"},{"key":"3069_CR122","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1523\/JNEUROSCI.21-19-07491.2001","volume":"21","author":"EM Talley","year":"2001","unstructured":"Talley EM, Solorzano G, Lei Q, Kim D, Bayliss DA. Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci. 2001;21:7491\u2013505.","journal-title":"J Neurosci"},{"key":"3069_CR123","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0169-328X(00)00263-1","volume":"86","author":"AD Medhurst","year":"2001","unstructured":"Medhurst AD, Rennie G, Chapman CG, Meadows H, Duckworth MD, Kelsell RE, et al. Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res Mol Brain Res. 2001;86:101\u201314.","journal-title":"Brain Res Mol Brain Res"},{"key":"3069_CR124","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/bph.12953","volume":"172","author":"M Borsotto","year":"2015","unstructured":"Borsotto M, Veyssiere J, Moha Ou Maati H, Devader C, Mazella J, Heurteaux C. Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept. Br J Pharmacol. 2015;172:771\u201384. https:\/\/doi.org\/10.1111\/bph.12953","journal-title":"Br J Pharmacol"},{"key":"3069_CR125","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/sj.bjp.0706068","volume":"144","author":"LE Kennard","year":"2005","unstructured":"Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, Veale EL, Mathie A. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br J Pharmacol. 2005;144:821\u20139. https:\/\/doi.org\/10.1038\/sj.bjp.0706068","journal-title":"Br J Pharmacol"},{"key":"3069_CR126","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainres.2011.08.021","volume":"1416","author":"AL Gotter","year":"2011","unstructured":"Gotter AL, Santarelli VP, Doran SM, Tannenbaum PL, Kraus RL, Rosahl TW, et al. TASK-3 as a potential antidepressant target. Brain Res. 2011;1416:69\u201379. https:\/\/doi.org\/10.1016\/j.brainres.2011.08.021","journal-title":"Brain Res"},{"key":"3069_CR127","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/nn1749","volume":"9","author":"C Heurteaux","year":"2006","unstructured":"Heurteaux C, Lucas G, Guy N, El Yacoubi M, Th\u00fcmmler S, Peng XD, et al. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci. 2006;9:1134\u201341. https:\/\/doi.org\/10.1038\/nn1749","journal-title":"Nat Neurosci"},{"key":"3069_CR128","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1523\/JNEUROSCI.22-04-01256.2002","volume":"22","author":"CP Washburn","year":"2002","unstructured":"Washburn CP, Sirois JE, Talley EM, Guyenet PG, Bayliss DA. Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K+ conductance. J Neurosci. 2002;22:1256\u201365.","journal-title":"J Neurosci"},{"key":"3069_CR129","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.mcn.2008.07.005","volume":"39","author":"PY Deng","year":"2008","unstructured":"Deng PY, Lei S. Serotonin increases GABA release in rat entorhinal cortex by inhibiting interneuron TASK-3 K+ channels. Mol Cell Neurosci. 2008;39:273\u201384. https:\/\/doi.org\/10.1016\/j.mcn.2008.07.005","journal-title":"Mol Cell Neurosci"},{"key":"3069_CR130","doi-asserted-by":"publisher","unstructured":"Bo\u017ei\u0107 M, Pirnat S, Fink K, Potokar M, Kreft M, Zorec R, et al. Ketamine reduces the surface density of the astroglial Kir4.1 channel and inhibits voltage-activated currents in a manner similar to the action of Ba(2+) on K(+) currents. Cells. 2023;12. https:\/\/doi.org\/10.3390\/cells12101360","DOI":"10.3390\/cells12101360"},{"key":"3069_CR131","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1523\/jneurosci.0765-04.2004","volume":"24","author":"C Yue","year":"2004","unstructured":"Yue C, Yaari Y. KCNQ\/M channels control spike afterdepolarization and burst generation in hippocampal neurons. J Neurosci. 2004;24:4614\u201324. https:\/\/doi.org\/10.1523\/jneurosci.0765-04.2004","journal-title":"J Neurosci"},{"key":"3069_CR132","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/aps.2017.72","volume":"38","author":"H Peng","year":"2017","unstructured":"Peng H, Bian XL, Ma FC, Wang KW. Pharmacological modulation of the voltage-gated neuronal Kv7\/KCNQ\/M-channel alters the intrinsic excitability and synaptic responses of pyramidal neurons in rat prefrontal cortex slices. Acta Pharmacol Sin. 2017;38:1248\u201356. https:\/\/doi.org\/10.1038\/aps.2017.72","journal-title":"Acta Pharmacol Sin"},{"key":"3069_CR133","doi-asserted-by":"publisher","first-page":"100187","DOI":"10.1016\/j.ynstr.2019.100187","volume":"11","author":"AFT Arnsten","year":"2019","unstructured":"Arnsten AFT, Jin LE, Gamo NJ, Ramos B, Paspalas CD, Morozov YM, et al. Role of KCNQ potassium channels in stress-induced deficit of working memory. Neurobiol Stress. 2019;11:100187. https:\/\/doi.org\/10.1016\/j.ynstr.2019.100187","journal-title":"Neurobiol Stress"},{"key":"3069_CR134","doi-asserted-by":"publisher","unstructured":"O\u2019Donovan B, Adeluyi A, Anderson EL, Cole RD, Turner JR, Ortinski PI. Altered gating of K(v)1.4 in the nucleus accumbens suppresses motivation for reward. Elife 2019;8. https:\/\/doi.org\/10.7554\/eLife.47870","DOI":"10.7554\/eLife.47870"},{"key":"3069_CR135","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroscience.2020.06.002","volume":"442","author":"S Moriguchi","year":"2020","unstructured":"Moriguchi S, Inagaki R, Shimojo H, Sugimura Y, Fukunaga K. Memantine improves depressive-like behaviors via Kir6.1 channel inhibition in olfactory bulbectomized mice. Neuroscience. 2020;442:264\u201373. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.06.002","journal-title":"Neuroscience"},{"key":"3069_CR136","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1021\/acschemneuro.8b00225","volume":"9","author":"X Qi","year":"2018","unstructured":"Qi X, Xu H, Wang L, Zhang Z. Comparison of therapeutic effects of TREK1 blockers and fluoxetine on chronic unpredicted mild stress sensitive rats. ACS Chem Neurosci. 2018;9:2824\u201331. https:\/\/doi.org\/10.1021\/acschemneuro.8b00225","journal-title":"ACS Chem Neurosci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-03069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-03069-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-03069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T15:25:44Z","timestamp":1727882744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-03069-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3069"],"URL":"https:\/\/doi.org\/10.1038\/s41398-024-03069-6","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"411"}}